Skip to main content

Table 3 Multivariate analysis of 5-year disease-free survival and melanoma-specific survival

From: Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors

Clinical and pathological factors

Disease-free survival

P value

Melanoma-specific survival

P value

Method of diagnosis

 

0.6

 

0.01

Sentinel lymph node biopsy

1

 

1

 

Clinical

1.1 (0.7 to 1.7)

 

1.7 (1.0 to 3.0)

 

Primary sitea

 

0.05

 

0.07

Trunk

1

 

1

 

Lower extremity

0.5 (0.3 to 0.9)

 

0.6 (0.3 to 1.1)

 

Unknown

1.1 (0.3 to 3.6)

 

21.7 (0.5 to 5.6)

 

T stage

 

0.05

 

0.09

T1 to T2

1

 

1

 

T3

2.2 (1.2 to 4.1)

 

2.5 (1.1 to 5.6)

 

T4

1.6 (0.8 to 3.0)

 

1.6 (0.6 to 3.8)

 

Ulcerationb

 

0.3

 

0.06

No

1

 

1

 

Yes

1.3 (0.7 to 2.3)

 

1.9 (1.0 to 3.7)

 

Number of positive lymph nodes

 

0.006

 

0.003

1 (N1)

1

 

1

 

2 or 3 (N2)

1.2 (0.6 to 2.2)

 

1.6 (0.7 to 3.5)

 

≥4 (N3)

3.6 (1.6 to 7.8)

 

4.7 (1.9 to 11.5)

 

Extent of nodal involvement

 

0.001

 

0.002

Superficial

1

 

1

 

Superficial + deep

2.6 (1.4 to 4.6)

 

2.8 (1.5 to 5.5)

Â